INOZYME PHARMA, INC. Operating Lease, Liability, Current
INOZYME PHARMA, INC. had Operating Lease, Liability, Current of $669.00 thousand as of 2025-03-31, per its 10-Q filed 2025-05-14.
Financial Statements › Notes › Leases
us-gaap:OperatingLeaseLiabilityCurrent · last filed 2025-05-14
- 2025-03-31: Operating Lease, Liability, Current $669.00K.
- 2024-12-31: Operating Lease, Liability, Current $913.00K.
- 2024-09-30: Operating Lease, Liability, Current $985.00K.
- 2024-06-30: Operating Lease, Liability, Current $959.00K.
| Period end | Operating Lease, Liability, Current |
|---|---|
| 2025-03-31 | $669.00K 10-Q · filed 2025-05-14 |
| 2024-12-31 | $913.00K 10-Q · filed 2025-05-14 |
| 2024-09-30 | $985.00K 10-Q · filed 2024-11-05 |
| 2024-06-30 | $959.00K 10-Q · filed 2024-08-06 |
| 2024-03-31 | $934.00K 10-Q · filed 2024-05-07 |
| 2023-12-31 | $910.00K 10-K · filed 2025-03-10 |
| 2023-09-30 | $886.00K 10-Q · filed 2023-11-07 |
| 2023-06-30 | $862.00K 10-Q · filed 2023-08-08 |
| 2023-03-31 | $839.00K 10-Q · filed 2023-05-09 |
| 2022-12-31 | $816.00K 10-K · filed 2024-03-12 |
| 2022-09-30 | $794.00K 10-Q · filed 2022-11-10 |
| 2022-06-30 | $773.00K 10-Q · filed 2022-08-15 |
| 2022-03-31 | $752.00K 10-Q · filed 2022-05-10 |
| 2021-12-31 | $731.00K 10-K · filed 2023-03-22 |
| 2021-09-30 | $711.00K 10-Q · filed 2021-11-09 |
| 2021-06-30 | $691.00K 10-Q · filed 2021-08-11 |
| 2021-03-31 | $672.00K 10-Q · filed 2021-05-12 |
| 2020-12-31 | $0.00 10-K · filed 2022-03-15 |